Hospital
Vassar Health Connecticut, INC.
Vassar Health Connecticut, INC. was paid $5.78M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoVASSAR HEALTH CONNECTICUT, INC.
SHARON, CT 06069
SHARON, CT 06069
33aNPI1235131442assigned 06/01/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.78M
24GClaims134,294
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Connecticut
Rank by total paid#11 of 18
Median peer was paid$15.60M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,806 | $568K | |
| 2019 | 15,729 | $650K | |
| 2020 | 15,809 | $667K | |
| 2021 | 18,010 | $882K | |
| 2022 | 18,510 | $949K | |
| 2023 | 25,243 | $1.04M | |
| 2024incomplete | 22,187 | $1.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 7,070 | 6,422 | $1.16M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 5,529 | 4,751 | $1.10M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 3,338 | 2,631 | $882K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8.1% | 8,480 | 2,420 | $466K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.0% | 2,350 | 1,873 | $291K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.5% | 3,602 | 2,677 | $261K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.8% | 1,082 | 919 | $219K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.6% | 1,672 | 1,534 | $208K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 1,018 | 828 | $135K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 2,484 | 2,184 | $101K |
| 80053 | Comprehensive metabolic panel | 1.5% | 11,198 | 8,766 | $87K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.4% | 5,106 | 1,620 | $80K |
111 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 327 | $73K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 608 | $66K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 698 | $57K |
| 73564 | <1% | 693 | $48K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,724 | $47K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 543 | $44K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 639 | $43K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,960 | $40K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,222 | $39K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 752 | $36K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 812 | $26K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 168 | $24K |
| 73030 | <1% | 637 | $23K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,778 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,987 | $21K |
| 80061 | Lipid panel | <1% | 2,398 | $17K |
| 97161 | <1% | 246 | $16K | |
| 73610 | <1% | 429 | $13K | |
| 72100 | <1% | 232 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 383 | $9K |
| 73130 | <1% | 324 | $9K | |
| 86618 | <1% | 930 | $8K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 256 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 256 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,799 | $7K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 29 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,229 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,154 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,326 | $5K |
| 86900 | <1% | 101 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 719 | $4K |
| 73110 | <1% | 156 | $4K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $3K |
| 84439 | <1% | 747 | $3K | |
| 86617 | <1% | 221 | $3K | |
| 73630 | <1% | 156 | $2K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 191 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 120 | $2K |
| 82607 | <1% | 287 | $2K | |
| 85610 | <1% | 2,011 | $2K | |
| 86666 | <1% | 237 | $2K | |
| 83880 | <1% | 180 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,045 | $2K |
| 86753 | <1% | 116 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 542 | $2K |
| 86703 | <1% | 130 | $1K | |
| 83735 | <1% | 958 | $1K | |
| 84481 | <1% | 116 | $988.98 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,725 | $975.77 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 44 | $950.00 |
| 86780 | <1% | 101 | $846.88 | |
| 83690 | <1% | 1,347 | $752.63 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 43 | $747.76 |
| 81003 | <1% | 1,984 | $738.20 | |
| 73502 | <1% | 42 | $709.74 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 15 | $665.02 |
| 87400 | <1% | 1,276 | $609.50 | |
| 85651 | <1% | 405 | $592.48 | |
| 81001 | <1% | 1,707 | $533.10 | |
| 86609 | <1% | 78 | $489.66 | |
| 87338 | <1% | 58 | $449.68 | |
| 87340 | <1% | 44 | $365.19 | |
| 86140 | <1% | 183 | $340.04 | |
| 86850 | <1% | 90 | $337.41 | |
| 86592 | <1% | 83 | $288.97 | |
| 84703 | <1% | 1,327 | $269.48 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 16 | $252.35 |
| 84484 | <1% | 1,737 | $250.45 | |
| 87070 | <1% | 40 | $216.00 | |
| 86762 | <1% | 16 | $165.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 211 | $164.93 |
| 80306 | <1% | 30 | $151.05 | |
| 82947 | <1% | 107 | $146.92 | |
| 86901 | <1% | 101 | $144.94 | |
| 87081 | <1% | 491 | $129.21 | |
| 87077 | <1% | 88 | $108.21 | |
| 85652 | <1% | 77 | $102.64 | |
| 85730 | <1% | 121 | $97.97 | |
| 83605 | <1% | 475 | $90.18 | |
| 87186 | <1% | 65 | $71.07 | |
| 82150 | <1% | 13 | $49.52 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,927 | $49.42 |
| 85379 | <1% | 93 | $38.70 | |
| 85027 | <1% | 19 | $37.08 | |
| 87430 | <1% | 550 | $34.73 | |
| 85007 | <1% | 32 | $29.52 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,134 | $28.37 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,157 | $24.94 |
| 87420 | <1% | 93 | $21.22 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,249 | $12.18 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $11.45 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 21 | $6.50 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 634 | $4.99 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 100 | $4.80 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 547 | $1.27 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,823 | $1.11 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 133 | $0.00 |
| 93041 | 0% | 14 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 477 | $0.00 |
| 87040 | 0% | 26 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 227 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 145 | $0.00 |
| 85008 | 0% | 65 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 228 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 71 | $0.00 |
| 96376 | 0% | 69 | $0.00 | |
| 80320 | 0% | 15 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 729 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 22 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBACHER, KATHERINE (VP FINANCIAL OPERATIONS)